BioCardia, Inc. (BCDA)
1.11
+0.03
(+2.78%)
USD |
NASDAQ |
Sep 08, 16:00
1.12
+0.01
(+0.90%)
Pre-Market: 20:00
BioCardia Debt to Equity Ratio : 0.1085 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1085 |
| March 31, 2026 | -0.3865 |
| December 31, 2025 | 0.5899 |
| September 30, 2025 | 0.2429 |
| June 30, 2025 | -0.395 |
| March 31, 2025 | -0.5592 |
| December 31, 2024 | 1.136 |
| September 30, 2024 | 0.3796 |
| June 30, 2024 | -0.5803 |
| March 31, 2024 | -0.5398 |
| December 31, 2023 | -0.8203 |
| September 30, 2023 | -2.118 |
| June 30, 2023 | 0.904 |
| March 31, 2023 | 0.8184 |
| December 31, 2022 | 0.3334 |
| September 30, 2022 | 0.4154 |
| June 30, 2022 | 0.2628 |
| March 31, 2022 | 0.2501 |
| December 31, 2021 | 0.18 |
| September 30, 2021 | 0.012 |
| June 30, 2021 | 0.0202 |
| March 31, 2021 | 0.0252 |
| December 31, 2020 | 0.032 |
| September 30, 2020 | 0.3068 |
| June 30, 2020 | 0.1911 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.7919 |
| December 31, 2019 | 0.4819 |
| September 30, 2019 | 0.2426 |
| June 30, 2019 | -0.6145 |
| March 31, 2019 | 1.815 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Cytokinetics, Inc. | -7.324 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 4.755M |
| Total Liabilities (Quarterly) | 2.055M |
| Shareholders Equity (Quarterly) | 2.70M |
| Current Ratio | 2.092 |
| Net Debt Paydown Yield | 0.60% |